How it started
History
In 1994, Glen de Vries and Ed Ikeguchi created OceanTek, a startup that developed Web applications for conducting clinical trials and was the precursor to Medidata. In 1999, along with Tarek Sherif, Glen de Vries and Ed Ikeguchi founded Medidata Solutions to provide online systems for designing and running clinical trials. In 2004, they completed a $10 million round of financing with Insight Venture Partners, and were later backed by investors including Milestone Venture Partners and Stonehenge Capital Fund. Ikeguchi left the company in 2008. Medidata acquired Fast Track Systems (clinical trial planning software) in 2008.
On January 26, 2009, Medidata filed to raise $86 million in an initial public offering (IPO). It made its IPO on the Nasdaq Stock Market on June 25, 2009, with its market capitalization at $313 million. It debuted on the Nasdaq at $18 per share. Medidata acquired Clinical Force (SaaS-based clinical trial management systems) in 2011, Patient Profiles (Clinical trial data quality improvement) in 2014, Intelemage (medical image sharing technology) in 2016, Chita (cloud-based content management system) and Mytrus (clinical trial technology) in 2017, and SHYFT Analytics (cloud data analytics) in 2018. In April 2019, Medidata launched Acorn AI, an AI-oriented solution based on its own trained data.
As of 2017, Medidata customers include 18 of the world's top 25 pharmaceutical companies, with clients such as Johnson & Johnson, AstraZeneca, Amgen, Cancer Research UK, GlaxoSmithKline, Novartis and Hoffmann-La Roche.
In December 2019, Medidata was acquired by Dassault Systèmes for $5.8 billion. Medidata acquired MC10 (digital biomarker technology) in 2020.
From Wikipedia’s article on MEDIDATA, shared under CC BY-SA 4.0.3